Share

September 03, 2013; 81 (10) Global Perspectives

The global epidemiology of herpes zoster

Barbara P. Yawn, Don Gilden
First published September 2, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a3516e
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
5403

Share

Article Information

vol. 81 no. 10 928-930
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a3516e
PubMed: 
23999562
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published September 2, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Barbara P. Yawn, MD and
    2. Don Gilden, MD
  1. Barbara P. Yawn, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Respiratory Medicine, Associate Editor, 2008-2015 Respiratory Medicine CME, Editor in Chief, 2012-2014 Mayo Clinic Proceedings, Section Editor, Epidemiology, 2009-2015 Minnesota Medicine, Editoral Board, 2000-2015

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Merck, consultant related to herpes zoster epidemiology

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Merck study on epidemiology of HZ and second study on HZ eye complications epidemiology and natural history.

    Research Support, Government Entities:

    1. CDC, study on HZ surveillance and HZ risk factors

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Don Gilden, MD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Merck Laboratories, speaker honorarium

    Editorial Boards:

    1. (1) Journal of NeuroVirology, Senior Associate Editor, 1995-present (2) In Vivo,editorial board, 2002-present (3) Journal of Virology, editorial board, 2003-present (4) Scientific American Medicine, editorial board, 2004- present (5) Virus Genes, editorial board, 2006-present (6) Neurology, editorial board, 2009-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH P01 AG032958, Program Director, 03/01/09-02/28/14 (2) NIH R01 AG006127, Principal Investigator, 09/01/10- 08/31/15 (4) NIH T32 NS007321, Program Director, 07/01/10-06/30/15

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Research (B.P.Y.), Olmsted Medical Center, Rochester, MN; and Departments of Neurology and Microbiology (D.G.), University of Colorado School of Medicine, Aurora.
  1. Correspondence to Dr. Gilden: Don.Gilden{at}ucdenver.edu
View Full Text

Article usage

Article usage: August 2013 to May 2023

AbstractFullPdfSource
Aug 20132214Highwire
Sep 2013372240264Highwire
Oct 20135312683Highwire
Nov 2013378953Highwire
Dec 2013187047Highwire
Jan 20141510479Highwire
Feb 20141612179Highwire
Mar 20143311272Highwire
Apr 2014189146Highwire
May 201477352Highwire
Jun 2014367451Highwire
Jul 2014246828Highwire
Aug 2014204735Highwire
Sep 201495633Highwire
Oct 2014154331Highwire
Nov 2014203437Highwire
Dec 2014202015Highwire
Jan 2015202916Highwire
Jan 201504129pmc
Feb 201519217Highwire
Feb 201503619pmc
Mar 2015312026Highwire
Mar 201506845pmc
Apr 2015387127Highwire
Apr 201504121pmc
May 2015242613Highwire
May 201505535pmc
Jun 2015241315Highwire
Jun 201503943pmc
Jul 2015321917Highwire
Jul 201504432pmc
Aug 2015292922Highwire
Aug 201504526pmc
Sep 2015482430Highwire
Sep 201504621pmc
Oct 2015401924Highwire
Oct 201503723pmc
Nov 2015361524Highwire
Nov 201505532pmc
Dec 2015321412Highwire
Dec 201503512pmc
Jan 2016483118Highwire
Jan 201603118pmc
Feb 2016422223Highwire
Feb 201606021pmc
Mar 2016603342Highwire
Mar 201603815pmc
Apr 2016613221Highwire
Apr 201604316pmc
May 2016591316Highwire
May 201604813pmc
Jun 2016772020Highwire
Jun 201603213pmc
Jul 2016322422Highwire
Jul 201603215pmc
Aug 2016261613Highwire
Aug 201605027pmc
Sep 2016502115Highwire
Sep 201603815pmc
Oct 2016593321Highwire
Oct 201605223pmc
Nov 2016411720Highwire
Nov 201604121pmc
Dec 2016412125Highwire
Dec 201603418pmc
Jan 2017241111Highwire
Jan 201704111pmc
Feb 2017351913Highwire
Feb 201705516pmc
Mar 2017502016Highwire
Mar 2017010221pmc
Apr 2017391121Highwire
Apr 2017115659pmc
May 2017212014Highwire
May 2017175478pmc
Jun 201717117Highwire
Jun 2017113638pmc
Jul 201715189Highwire
Jul 2017165358pmc
Aug 2017231514Highwire
Aug 2017257894pmc
Sep 2017292010Highwire
Sep 2017156974pmc
Oct 2017412825Highwire
Oct 201724116132pmc
Nov 2017331918Highwire
Nov 201714101111pmc
Dec 201712177Highwire
Jan 2018104916Highwire
Feb 2018334922Highwire
Mar 2018152915Highwire
Apr 201815669Highwire
Apr 201825167188pmc
May 2018155314Highwire
Jun 201895020Highwire
Jun 201811123156pmc
Jul 20187504Highwire
Aug 201853612Highwire
Aug 201815173216pmc
Sep 2018243812Highwire
Oct 2018153823Highwire
Nov 201893916Highwire
Dec 201892110Highwire
Jan 201983114Highwire
Feb 2019124614Highwire
Mar 2019174023Highwire
Apr 2019253715Highwire
May 2019223920Highwire
Jun 2019134116Highwire
Jul 2019132917Highwire
Aug 201994618Highwire
Sep 20198243Highwire
Oct 2019214311Highwire
Nov 2019105522Highwire
Dec 2019143916Highwire
Jan 2020104518Highwire
Feb 2020174232Highwire
Mar 2020146720Highwire
Apr 202084321Highwire
May 2020205321Highwire
Jun 2020206735Highwire
Jul 202094531Highwire
Aug 202064115Highwire
Sep 20201230029Highwire
Oct 2020126434Highwire
Nov 2020198360Highwire
Dec 2020175919Highwire
Jan 2021113627Highwire
Feb 2021173927Highwire
Mar 2021337138Highwire
Apr 20212610045Highwire
May 2021227343Highwire
Jun 202197747Highwire
Jul 20211610751Highwire
Aug 2021158948Highwire
Sep 2021238128Highwire
Oct 2021249355Highwire
Nov 2021208854Highwire
Dec 2021139348Highwire
Jan 2022146739Highwire
Feb 20222610036Highwire
Mar 20223019653Highwire
Apr 20223817262Highwire
May 20224021961Highwire
Jun 20222811944Highwire
Jul 20221813323Highwire
Aug 20222918034Highwire
Sep 20224517242Highwire
Oct 20223915644Highwire
Nov 20225017355Highwire
Dec 20223514342Highwire
Jan 20232517637Highwire
Feb 20232517037Highwire
Mar 20234315950Highwire
Apr 20234514034Highwire
May 20233613734Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles